We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

M:BVBMed Life SA Analysis

Data as of 2026-06-22 - not real-time

$24.14

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical momentum is firmly bullish – the price sits above its short‑, medium‑ and long‑term moving averages, the MACD line is above its signal, and the RSI is in the upper‑mid range, suggesting continued upside pressure.
Fundamentals present a mixed picture – earnings have shown modest growth and the dividend yield is attractive with a comfortable payout ratio, yet profit margins are thin, debt levels are high relative to equity, and the stock trades at a premium to its discounted cash‑flow estimate, indicating limited upside and potential overvaluation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical indicators
  • Recent earnings beat and raised guidance
  • Price near recent resistance with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield and sustainable payout
  • Thin profit margins and high leverage
  • Valuation above intrinsic estimate

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable cash flow supporting dividend continuity
  • Consumer‑cyclical exposure to economic cycles
  • Elevated debt and modest revenue growth limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin2.94%
P/E Ratio10.0
ROE14.36%
ROA3.37%
Debt/Equity105.62
P/B Ratio1.3
Op. Cash Flow$1.8B
Free Cash Flow$748.9M

Technical Analysis

TrendBullish
RSI62.6
Support$19.61
Resistance$25.65
MA 20$22.72
MA 50$20.68
MA 200$20.08
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value$26.53
Target Price$21.55
Upside/Downside-10.73%
GradeOvervalued
TypeValue
Dividend Yield3.17%

Risk Assessment

Beta1.23
Volatility50.73%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.